BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9667455)

  • 1. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil.
    Clark SM; Wilkinson SM
    Contact Dermatitis; 1998 May; 38(5):289-90. PubMed ID: 9667455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bullous phototoxic contact dermatitis caused by Ruta graveolens L. (garden rue), Rutaceae. Case report and review of literature].
    Schempp CM; Schöpf E; Simon JC
    Hautarzt; 1999 Jun; 50(6):432-4. PubMed ID: 10427513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
    Grundmann-Kollmann M; Leiter U; Behrens S; Gottlöber P; Mooser G; Krähn G; Kerscher M
    Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultraviolet A-induced photodegradation of 5-methoxypsoralen, 8-methoxypsoralen and psoralen reduces the biological effectiveness of the furocoumarins in vivo.
    Knudsen EA; Bech-Thomsen N; Wulf HC
    Photodermatol Photoimmunol Photomed; 1995 Jun; 11(3):131-3. PubMed ID: 8555012
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of phototoxic and photogenotoxic risk associated with the use of photosensitizers in suntan preparations: application to tanning preparations containing bergamot oil.
    Moysan A; Morlière P; Averbeck D; Dubertret L
    Skin Pharmacol; 1993; 6(4):282-91. PubMed ID: 8198814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatitis bullosa striata pratensis caused by Dictamnus albus L. (burning bush)].
    Schempp CM; Sonntag M; Schöpf E; Simon JC
    Hautarzt; 1996 Sep; 47(9):708-10. PubMed ID: 8999028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact allergy to 8-methoxypsoralen.
    Korffmacher H; Hartwig R; Matthes U; Dirschka T; Albassam A; Weindorf N; Altmeyer P
    Contact Dermatitis; 1994 May; 30(5):283-5. PubMed ID: 8088142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polychromatic action spectrum for photosensitivity to orally administered 8-methoxypsoralen in humans.
    Bech-Thomsen N; Wulf HC
    Clin Exp Dermatol; 1994 Jan; 19(1):12-5. PubMed ID: 8313631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototesting and phototoxic side effects in bath PUVA.
    Calzavara-Pinton PG; Ortel B; Carlino AM; Honigsmann H; De Panfilis G
    J Am Acad Dermatol; 1993 Apr; 28(4):657-9. PubMed ID: 8463475
    [No Abstract]   [Full Text] [Related]  

  • 11. Accidental bullous phototoxic reactions to bergamot aromatherapy oil.
    Kaddu S; Kerl H; Wolf P
    J Am Acad Dermatol; 2001 Sep; 45(3):458-61. PubMed ID: 11511848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery.
    Degitz K; Plewig G; Röcken M
    Arch Dermatol; 1996 Nov; 132(11):1394-5. PubMed ID: 8915330
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis to 5-methoxypsoralen during photochemotherapy.
    Legat FJ; Wolf P; Kränke B
    Br J Dermatol; 2001 Nov; 145(5):821-2. PubMed ID: 11736909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototoxic Contact Dermatitis From Over-the-counter 8-Methoxypsoralen.
    Atwal SK; Chen A; Adler BL
    Cutis; 2022 Feb; 109(2):E2-E3. PubMed ID: 35659812
    [No Abstract]   [Full Text] [Related]  

  • 17. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid formulations of 8-methoxypsoralen (8-MOP) and 5-MOP: a prospective double-blind crossover assessment of acute non-phototoxic adverse effects.
    George SA; Ferguson J
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):33-5. PubMed ID: 1390121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action spectrum for bergamot-oil phototoxicity measured by sunburn cell counting.
    Yasui Y; Hirone T
    J Dermatol; 1994 May; 21(5):319-22. PubMed ID: 8051317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.